Kansas State UniversityAssociate Professor of Biochemistry & Molecular Biophysics
Jan. 2017 - Dec. 2022Manhattan, KSCurrently volunteer adjunct status. Research is in AI drug discovery for cancer, immunology, and infectious disease. Previous research program was in computational structural biology/chemistry and protein crystallography, with a focus on machine learning, structure-based drug design, molecular dynamics, virtual screening, cancer, immunology, malaria, COVID19. Projects included RORgamma, SHP2, EZH2, drug resistant estrogen receptor, aromatase, fluorescent proteins, applications of machine learning to chemistry and drug discovery, identification of druggable sites on proteins, malarial kinases, GPCRs. Founder of OSC19, an open source drug discovery consortium for COVID-19. Anti-aging drug discovery Biophysical interests include developing methods for analyzing hydrogen atoms in x-ray and neutron crystallography data, super-resolution image processing of microscopy images, and biosensor proteins. We have also discovered potent RORgamma antagonists, aromatase inhibitors, an SHP2 inhibitor, and an EZH2 inhibitor. Taught advanced biochemistry, biochemistry for non-majors, medical biochemistry, molecular biophysics, general chemistry.